Skip to main content
Journal ArticleOPEN ACCESS

Subcutaneous omalizumab for people with asthma

Cochrane Database of Systematic Reviews (2021) 2021(7)
DOI: 10.1002/14651858.CD014975
0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effects of subcutaneous omalizumab versus placebo for asthma in adults and children.

Cite

CITATION STYLE

APA

Donovan, T., Milan, S. J., Adatia, A., Solkar, Z., Stovold, E., Dwan, K., … Crossingham, I. (2021). Subcutaneous omalizumab for people with asthma. Cochrane Database of Systematic Reviews, 2021(7). https://doi.org/10.1002/14651858.CD014975

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free